These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34126129)

  • 41. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuous glucose monitoring - a new and expanding element in the care of patients with diabetes mellitus during pregnancy.
    Urbanová Jana; Brunerová Ludmila; Janíčková Žďárská Denisa; Doničová Viera; Brož Jan
    Ceska Gynekol; 2021; 86(6):406-409. PubMed ID: 35038880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose Variability: A Review of Clinical Applications and Research Developments.
    Rodbard D
    Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
    Lu J; Ma X; Zhou J; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Vigersky RA; Jia W
    Diabetes Care; 2018 Nov; 41(11):2370-2376. PubMed ID: 30201847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial.
    Brown SA; Beck RW; Raghinaru D; Buckingham BA; Laffel LM; Wadwa RP; Kudva YC; Levy CJ; Pinsker JE; Dassau E; Doyle FJ; Ambler-Osborn L; Anderson SM; Church MM; Ekhlaspour L; Forlenza GP; Levister C; Simha V; Breton MD; Kollman C; Lum JW; Kovatchev BP;
    Diabetes Care; 2020 Aug; 43(8):1822-1828. PubMed ID: 32471910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.
    Garg S; Zisser H; Schwartz S; Bailey T; Kaplan R; Ellis S; Jovanovic L
    Diabetes Care; 2006 Jan; 29(1):44-50. PubMed ID: 16373894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes.
    Gawrecki A; Zozulinska-Ziolkiewicz D; Michalak MA; Adamska A; Michalak M; Frackowiak U; Flotynska J; Pietrzak M; Czapla S; Gehr B; Araszkiewicz A
    PLoS One; 2021; 16(4):e0248965. PubMed ID: 33819289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustainable Use of a Real-Time Continuous Glucose Monitoring System from 2018 to 2020.
    van der Linden J; Welsh JB; Walker TC
    Diabetes Technol Ther; 2021 Jul; 23(7):508-511. PubMed ID: 33567233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of continuous glucose monitoring for type 2 in diabetes management and research.
    Vigersky R; Shrivastav M
    J Diabetes Complications; 2017 Jan; 31(1):280-287. PubMed ID: 27818105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study.
    Parise M; Tartaglione L; Cutruzzolà A; Maiorino MI; Esposito K; Pitocco D; Gnasso A; Irace C
    J Med Internet Res; 2021 Apr; 23(4):e24552. PubMed ID: 33769945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia.
    Davis TME; Dwyer P; England M; Fegan PG; Davis WA
    Diabetes Technol Ther; 2020 May; 22(5):367-373. PubMed ID: 31724878
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections.
    Volčanšek Š; Lunder M; Janež A
    Diabetes Technol Ther; 2019 Oct; 21(10):566-574. PubMed ID: 31335199
    [No Abstract]   [Full Text] [Related]  

  • 56. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
    Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
    Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of a new measure of blood glucose variability in diabetes.
    Kovatchev BP; Otto E; Cox D; Gonder-Frederick L; Clarke W
    Diabetes Care; 2006 Nov; 29(11):2433-8. PubMed ID: 17065680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
    Peyser TA; Nakamura K; Price D; Bohnett LC; Hirsch IB; Balo A
    Diabetes Technol Ther; 2015 Aug; 17(8):548-54. PubMed ID: 25961446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discordance between mean glucose and time in range in relation to HbA
    Sterner Isaksson S; Imberg H; Hirsch IB; Schwarcz E; Hellman J; Wijkman M; Bolinder J; Nyström T; Holmer H; Hallström S; Ólafsdóttir AF; Pekkari S; Polonsky W; Lind M
    Diabetologia; 2024 Apr; ():. PubMed ID: 38668761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of time in range on daily mood in adults with type 1 diabetes.
    Polonsky WH; Fortmann AL
    J Diabetes Complications; 2020 Dec; 34(12):107746. PubMed ID: 33077350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.